Reporting to the National Practitioner Data Bank (“NPDB”) is required when certain adverse clinical privilege actions involving professional competence or conduct of physicians occur. Reports submitted in response to negative actions or findings... Read More
On May 17, 2022, the United States District Court for the District of Columbia issued an opinion granting Summary Judgment to Pharmaceutical Research and Manufacturers of America (“PhRMA”), and setting aside the December 2020 Medicaid Best Price... Read More
Frier Levitt is pleased to announce the successful resolution of a federal investigation by the United States Attorney’s Office for the District of Maryland and the Drug Enforcement Administration (DEA) regarding alleged violations of the... Read More
Multiple states across the country have recently taken action and enacted new legislation to regulate Pharmacy Benefit Managers (“PBMs”). New York is no exception. Earlier in 2022, New York enacted comprehensive laws governing PBMs. More... Read More
In the healthcare industry, Management Services Organizations (“MSOs”) have become an increasingly popular tool utilized by medical practices for a variety of purposes. MSOs are administrative and management entities that develop relationships... Read More
As practices and payers are recovering from the pandemic, payers are getting “back to business”. Private and public payers alike are increasing their audits, returning to in-office inspections and using pre-payment reviews more than... Read More
Last week, Frier Levitt discussed here that Caremark overturned certain aspects of the bulk purchase restriction that was imposed on pharmacies earlier this year. Specifically, Caremark required pharmacies to request permission in writing prior to... Read More
Last week, the United States Department of Justice ("DOJ") announced that an orthopedic surgeon had been indicted by a federal grand jury due to his alleged involvement in a $10 million fraudulent healthcare scheme. According to the DOJ, the surgeon... Read More
As Frier Levitt reported here, earlier this year, CVS Caremark (“Caremark”) implemented a notification requirement for pharmacies making bulk purchases. Pharmacies that were looking to make bulk purchases that exceeded a “30 day supply”... Read More
Large chain pharmacies such as Walmart and CVS began refusing to fill or delaying Adderall and other ADHD drug prescriptions written by prescribers working for telehealth startups such as Cerebral and Done Health. As a result, other pharmacies who... Read More
